Name | 2-Hydroxy-1-naphthaldehyde salicyloylhydrazone |
---|---|
Synonyms |
2-Hydroxy-N'-[(E)-(2-hydroxy-1-naphthyl)methylene]benzohydrazide
2-Hydroxy-1-naphthaldehyde salicyloylhydrazone Benzoic acid, 2-hydroxy-, ((2-hydroxy-1-naphthalenyl)methylene)hydrazide Benzoic acid, 2-hydroxy-, 2-[(1E)-(2-hydroxy-1-naphthalenyl)methylene]hydrazide 2-Hydroxy-N'-[(E)-(2-hydroxy-1-naphthyl)methylidene]benzohydrazide |
Description | A nonnucleoside, competitive, small-molecule inhibitor of human ribonucleotide reductase (hRR) that binds to the large subunit hRRM1 at the catalytic site (C-site) with Kd of 37.4 uM, IC50 of 32 uM; has twofold IC50 of gemcitabine for growth inhibition of multiple cancer cell lines, while demonstrating little cytotoxicity against normal mobilized peripheral blood progenitor cells; depresses dGTP and dATP levels in the dNTP pool causing S-phase arrest, providing evidence for RR inhibition in cells. |
---|---|
References | References 1. Ahmad MF, et al. Proc Natl Acad Sci U S A. 2017 Jul 17. pii: 201620220. View Related Products by Target Nucleoside Antimetabolite/Analog |
Density | 1.3±0.1 g/cm3 |
---|---|
Molecular Formula | C18H14N2O3 |
Molecular Weight | 306.315 |
Exact Mass | 306.100433 |
LogP | 6.08 |
Index of Refraction | 1.647 |
Hazard Codes | Xi |
---|